The chances of price sensitive news coming soon for BDA are many...

The chances of price sensitive news coming soon for BDA are many and from various areas.

As far as the medicinal cannabis is concerned I'm particularly interested in seeing what happens in these 3 areas during the month of June.

Skincare – Nioskin
This is available to import immediately. Base products currently exist under the Nioskin™ brand including a serum, facial mist and a cream. Bod is finalising the import of these bases for development into products for sale in the Australian market. Bod will also develop other skincare products using Nioskin targeting the sensitive skin and elite sports market.

Therapeutic Extracts
With recent changes in the market, Bod is expecting to submit an application for an import licence for a finished good in the form of a therapeutic oil extract containing a standardised GMP manufactured extract.

Bod Australia executives have returned from meeting Linnea representatives at the company’s headquarters in Switzerland following the signing of a Letter of Intent by the two companies announced last month. Linnea’s representatives will visit Australia in June during which time they will meet with Government officials, the investor community and key stakeholders in Bod’s commercialisation plans.

Anyone here know when in June they are coming and anyone involved in the meeting process?